Konrad Frank

University of Cologne

Papers

1

Total Citations

36

H-Index

1

About

Konrad Frank is a radiation oncologist whose research has significantly advanced the use of stereotactic body radiation therapy (SBRT) for lung cancer. His work focuses on refining risk-adapted, non-invasive treatment strategies for patients with inoperable early-stage non-small-cell lung cancer, a population for whom traditional surgery is not an option. Frank’s most-cited paper, "Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer" (2017), has garnered 36 citations, reflecting its influence in establishing safer, more personalized dosing protocols that minimize toxicity while maintaining tumor control. This contribution has helped shape clinical guidelines and expand the role of robotic SBRT as a standard-of-care alternative. By integrating advanced imaging and motion management, Frank’s work underscores a commitment to improving both survival outcomes and quality of life for vulnerable patients. His research remains a cornerstone for oncologists seeking to optimize precision radiotherapy in thoracic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
36
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer
36 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: University of Cologne

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago